| Issue Date | Title | Author(s) |
| 2013-06-01 | Ciprofloxacin is actively transported across bronchial lung epithelial cells using a calu-3 air interface cell model | Ong, HX; Traini, D; Bebawy, M; Young, PM |
| 2011-01 | Cellular release profiling of controlled release dry powder pulmonary formulation | Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Young, PM |
| 2013-08-01 | Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: Implications in the treatment of chronic obstructive airway pathologies | Marin, L; Traini, D; Bebawy, M; Colombo, P; Buttini, F; Haghi, M; Ong, HX; Young, P |
| 2014-01 | Optimization of RPMI 2650 Cells as a Model for Nasal Mucosa | Pozzoli, M; Sonvico, F; Ong, HX; Traini, D; Bebawy, M; Young, P; Dalby, RN; Byron, PR; Peart, J; Suman, JD; Farr, SJ; Young, PM; Traini, D |
| 2011-09-01 | Epithelial profiling of antibiotic controlled release respiratory formulations | Ong, HX; Traini, D; Bebawy, M; Young, PM |
| 2012-12-01 | Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia | Ong, HX; Traini, D; Cipolla, D; Gonda, I; Bebawy, M; Agus, H; Young, PM |
| 2022-06 | Timothy Grass Pollen Induces Spatial Reorganisation of F-Actin and Loss of Junctional Integrity in Respiratory Cells. | Bradbury, P; Cidem, A; Mahmodi, H; Davies, JM; Spicer, PT; Prescott, SW; Kabakova, I; Ong, HX; Traini, D |
| 2022-04-02 | Application of Micro-Engineered Kidney, Liver, and Respiratory System Models to Accelerate Preclinical Drug Testing and Development. | Gholizadeh, H; Cheng, S; Kourmatzis, A; Xing, H; Traini, D; Young, PM; Ong, HX |
| 2018-08-01 | Repurposing of statins via inhalation to treat lung inflammatory conditions | Bradbury, P; Traini, D; Ammit, AJ; Young, PM; Ong, HX |
| 2014-01-01 | Across the pulmonary epithelial barrier: Integration of physicochemical properties and human cell models to study pulmonary drug formulations | Haghi, M; Ong, HX; Traini, D; Young, P |
